J-STAR Co Ltd

09/30/2026 | Press release | Distributed by Public on 09/30/2026 04:20

Sale of Shares of Caregiver Japan Co., Ltd.

Sale of Shares of Caregiver Japan Co., Ltd.

We are pleased to announce that the funds(*1) ("J-STAR Funds") to which J-STAR Co., Ltd. provides investment-related services have transferred all shares of Caregiver Japan Co., Ltd. (Head office: Minato-ku, Tokyo; Representative Director: Toshihiko Kagamiyama; hereinafter "Caregiver Japan") to CG-01 Co., Ltd. (Head office: Chiyoda-ku, Tokyo; hereinafter "CG-01").

CG-01 is a company established by a fund to which Nippon Investment Company Co., Ltd. (Head office: Chiyoda-ku, Tokyo) provides services, for the purpose of acquiring shares in this transaction.

Caregiver Japan is a provider of nursing care and medical-related services in the greater Tokyo area, offering home-based services including day services, welfare equipment rental, and visiting nursing care, as well as facility-based services including residential-type paid nursing homes and medical homes.

Since our investment in October 2022, J-STAR Funds have supported the expansion of business scale through enhanced new facility development, as well as the execution of management succession from the founder to the current president, thereby supporting the development of an organizational structure that enables sustainable growth.

With CG-01's support, we believe Caregiver Japan will achieve further growth and development.

(*1) J-STAR provides investment-related services to J-STAR No.4-A, LP, etc. directly or via subsidiaries, such as due diligence and recommendation of investment opportunities, and target company management support.

J-STAR Co Ltd published this content on September 30, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 30, 2026 at 10:20 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]